Biovation invests in equipment able to create any tablet on the market

By Maggie Lynch

- Last updated on GMT

(Image: Getty/Sazha Brazhnik)
(Image: Getty/Sazha Brazhnik)
Biovation expands its technology portfolio with all-encompassing tableting equipment to grow its production capacity and change specifications ‘on the fly’.

The company will expand its capabilities with the installation of a high speed rotary tablet press from Kikusi, an Aquarius G-J. The press can be tooled for each batch to exact specifications, enabling Biovation Labs, a contract manufacturer, to produce several million tablets each day.

Aquarius G-J can produce both regular tablets, as well as tablet-in-tablet products. Its imprinting capabilities also allows for each tablet to be branded with names, logos, images, embossing, and raised letters. The company stated that the equipment can change capabilities ‘on the fly’, adjusting to handle any batch of tablets.

A spokesperson from Biovation told us that this equipment adds additional flexibility and, through the investment, “clients are better served with the ability to produce almost any size and shape of tablet that is available on the market.”

The company is also adding new coating pans, equipment, and new personnel as part of its expansion.

“This investment enables the company to enhance how it serves its clients while maintaining the highest standards of quality,”​ the spokesperson added.

Financial details of the investment have not been disclosed. 

Related news

Show more

Related products

show more

Solution for challenging antibodies – Planova™ S20N

Solution for challenging antibodies – Planova™ S20N

Content provided by Asahi Kasei Medical Co., Ltd. | 24-Sep-2024 | White Paper

Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration performance for challenging molecules...

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us

Products

View more

Webinars